glp 1 drug tirzepatide Associated with Lower POAG, OHT Risk Compared with Other GLP-1 Drugs Semaglutide & Tirzepatide Weight Loss

Background Glucagon-like peptide-1 (GLP-1) induces diuresis and natriuresis

People are losing 15, 20 percent of their body weight

Preclinical and initial human studies suggest that glucagon-like peptide-1 receptor agonists may be promising treatments for alcohol use disorder, but existing approved treatments should be used until safety and efficacy is demonstrated in clinical trials.

Some potential concerns with long-term use of synthetic drugs include: Digestive discomfort (nausea, bloating, diarrhea) Possible nutrient absorption issues over time The need for ongoing injections or high-cost prescriptions Unknown effects from long-term artificial hormone stimulation Natural herbs and whole-food extracts work differentlythey support the bodys own GLP-1 production and related digestive functions rather than replacing or overriding them